Stéphane Verdood

Stéphane Verdood was the founder of Arthur Andersen (1995), holding the title of Principal; Vesalius Biocapital Partners SARL (2007), holding the title of Managing Partner; and Value For Growth NV (2001), holding the title of Managing Partner.
Current jobs include Chairman at Apitope International NV, Director at Trod Medical NV, Director at Apitope Technology (Bristol) Ltd., Director at Forendo Pharma Oy, Non-Executive Director at Scenic Biotech BV, and Manager at SGV Management Services BV.
Former jobs include Vice Chairman-Supervisory Board at Génomic Vision SA (2020-2022), Director at Calliditas Therapeutics Suisse SA, Director-Supervisory Board at Major SAS (2010-2014), Director at Biotechnological Enzymatic Catalyse NV, Director at Fast Forward Pharmaceuticals BV, Director at Genkyotex Innovation SAS, General Partner at Mara Venture Partners (2001-2006), and Member-Supervisory Board at Vesale Partners SAS. Education includes graduate and MBA from Katholieke Universiteit Leuven.